Acuta Capital Partners’s Rapport Therapeutics RAPP Stock Holding History

Acuta Capital Partners’s Portfolio RAPP Stock Details RAPP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$227K	Buy
2025 Q1	$164K	Hold
2024 Q4	$291K	Sell
2024 Q3	$360K	Sell
2024 Q2	$465K	Buy